The artificial pancreas—ready for prime time?

The Lancet Diabetes and Endocrinology

Volumn 5, Issue 4, 2017, Pages 238-239

  DeVries, J Hans ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN;

ARTIFICIAL PANCREAS; BLOOD GLUCOSE MONITORING; CLOSED LOOP INSULIN DELIVERY; CONCENTRATION (PARAMETERS); DRUG DELIVERY SYSTEM; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN PUMP; NOTE; SELF CARE;

HUMANS; PANCREAS, ARTIFICIAL;

EID: 85009414606     PISSN: 22138587     EISSN: 22138595     Source Type: Journal    
DOI: 10.1016/S2213-8587(17)30008-6     Document Type: Note

References (7)

1. 1 Bally, L, Thabit, H, Kojzar, H, et al. Day-and-night glycaemic control with closed-loop insulin delivery versus conventional insulin pump therapy in free-living adults with well controlled type 1 diabetes: an open-label, randomised, crossover study. Lancet Diabetes Endocrinol, 2017 published online Jan 13. http://dx.doi.org/10.1016/S2213-8587(17)30001-3.
2. 2 Thabit, H, Tauschmann, M, Allen, JM, et al. Home use of an artificial beta cell in type 1 diabetes. N Engl J Med 373 (2015), 2129–2140.
3. 3 Stewart, ZA, Wilinska, ME, Hartnell, S, et al. Closed-loop insulin delivery during pregnancy in women with type 1 diabetes. N Engl J Med 375 (2016), 644–654.
4. 4 Renard, E, Farret, A, Kropff, J, et al. Day-and-night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: results of a single-arm 1-month experience compared with a previously reported feasibility study of evening and night at home. Diabetes Care 39 (2016), 1151–1160.
5. 5 Kropff, J, Del Favero, S, Place, J, et al. 2 month evening and night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: a randomised crossover trial. Lancet Diabetes Endocrinol 3 (2015), 939–947.
6. 6 Bergenstal, RM, Garg, S, Weinzimer, SA, et al. Safety of a hybrid closed-loop insulin delivery system in patients with type 1 diabetes. JAMA 316 (2016), 1407–1408.
7. 7 DeVries, JH, Snoek, FJ, Kostense, PJ, Heine, RJ, Improved glycaemic control in type 1 diabetes patients following participation per se in a clinical trial—mechanisms and implications. Diabetes Metab Res Rev 19 (2003), 357–362.